公共咨询

医疗器械登记 到 ANVISA

按号码、产品、持有公司或CNPJ搜索,数据是ANVISA在公开数据中发布的,每天都会到达这里。

记录的 ROCHE DIAGNÓSTICA BRASIL LTDA取消

1,001 记录

产品持有公司班级有效性
D-DI2 (Tina-quant D-Dimer Gen.2 )_cobas c10287411559ROCHE DIAGNÓSTICA BRASIL LTDAIII01/02/2031
Família Elecsys SARS-CoV-2 Antigen10287411560ROCHE DIAGNÓSTICA BRASIL LTDAIII08/02/2031
SARS-CoV-2 Extraction Solution10287411561ROCHE DIAGNÓSTICA BRASIL LTDAI现有
cobas® prime Pre-analytical System10287411562ROCHE DIAGNÓSTICA BRASIL LTDAI现有
uPATH SOFTWARE10287411563ROCHE DIAGNÓSTICA BRASIL LTDAII现有
SARS-CoV-2 Antibody Control10287411564ROCHE DIAGNÓSTICA BRASIL LTDAIII08/03/2031
SARS-CoV-2 Antigen Control10287411565ROCHE DIAGNÓSTICA BRASIL LTDAIII08/03/2031
SARS-CoV-2 Rapid Antigen Test Nasal10287411566ROCHE DIAGNÓSTICA BRASIL LTDAIII03/05/2031
PreciControl Maternal Care10287411567ROCHE DIAGNÓSTICA BRASIL LTDAIII08/06/2036
QUIN2 Online TDM Quinidine_cobas c10287411568ROCHE DIAGNÓSTICA BRASIL LTDAIII06/10/2035
Família Elecsys Androstenedione10287411569ROCHE DIAGNÓSTICA BRASIL LTDAII现有
Elecsys EBV IgM10287411570ROCHE DIAGNÓSTICA BRASIL LTDAIV09/12/2034
Família Elecsys EBV EBNA IgG10287411571ROCHE DIAGNÓSTICA BRASIL LTDAIV04/11/2034
Família Elecsys EBV VCA IgG10287411572ROCHE DIAGNÓSTICA BRASIL LTDAIV18/11/2034
Elecsys Testosterone II10287411573ROCHE DIAGNÓSTICA BRASIL LTDAII现有
Elecsys FT3 III10287411574ROCHE DIAGNÓSTICA BRASIL LTDAII现有
Elecsys FSH10287411575ROCHE DIAGNÓSTICA BRASIL LTDAII现有
Elecsys Calcitonin10287411576ROCHE DIAGNÓSTICA BRASIL LTDAIII06/10/2035
Elecsys ß-CrossLaps/serum10287411577ROCHE DIAGNÓSTICA BRASIL LTDAII现有
cobas® PIK3CA Mutation Test10287411578ROCHE DIAGNÓSTICA BRASIL LTDAIII12/07/2031
Família Elecsys Anti-p5310287411579ROCHE DIAGNÓSTICA BRASIL LTDAIII16/08/2031
Famíília Elecsys CA 72-410287411580ROCHE DIAGNÓSTICA BRASIL LTDAIII16/08/2031
Elecsys PTH (1-84)10287411581ROCHE DIAGNÓSTICA BRASIL LTDAII现有
Elecsys ß-Amyloid (1-42) CSF II10287411582ROCHE DIAGNÓSTICA BRASIL LTDAII现有
Elecsys Phospho-Tau (181P) CSF10287411583ROCHE DIAGNÓSTICA BRASIL LTDAII现有

来源: ANVISA 开放数据,健康产品档案. 基础带来注册的有效性,而不是记录情况:注册可能在期限之前被取消,而不会在这里出现。 咨询门户 ANVISA.

接下来的步骤

您的产品需要在巴西注册

HSC在 ANVISA 中进行医疗器械登记,从风险类框架到过程跟踪。

联系专家